Literature DB >> 28001221

Number of leprosy reactions during treatment: clinical correlations and laboratory diagnosis.

Douglas Eulálio Antunes1,2, Gabriela Porto Ferreira1, Mariana Vitorino Candeiro Nicchio1,2, Sergio Araujo1,2, Ana Carolina Rodrigues da Cunha1,2, Rafaela Resende Gomes1, Adeilson Viera da Costa1, Isabela Maria Bernardes Goulart1,2.   

Abstract

INTRODUCTION: : The occurrence of leprosy reactions, a common event during treatment, may be mostly related to the action of multidrug therapy on Mycobacterium leprae. The clinical and laboratory monitoring of patients with reactions is important, since collecting data that assists in predicting the risk of reactions may help to prevent disability.
METHODS: : This was a sectional study, in order to correlate clinical and laboratory diagnosis with the number of reactions during treatment. Spearman's correlation was used to verify the degree of association between the assessed variables.
RESULTS: : This study was conducted with 211 patients with leprosy reactions during treatment of M. leprae. The borderline tuberculoid group was the most prevalent clinical form (74/211; 35.1%) and the type one reaction showed the highest frequency (136/211; 64.5%). It was observed that 73.5% (155/211) of reactions occurred within 3 months of the initiation of multidrug therapy. The diagnostic values, including the bacterial indices (BIs) of dermal smears (r = 0.21, p < 0.05) and skin biopsies (r = 0.20; p < 0.05), showed a positive correlation with the number of reactions during treatment.
CONCLUSIONS: : This research showed a positive correlation between bacillary load markers and the number of leprosy reactions. This study provided scientific support to future research aiming to elucidate the influence of antigenic load on the number of leprosy reactions during treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28001221     DOI: 10.1590/0037-8682-0440-2015

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

1.  Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy.

Authors:  Marlice Fernandes de Oliveira; Douglas Eulálio Antunes; Diogo Fernandes Dos Santos; Isabela Maria Bernardes Goulart
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

2.  Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study.

Authors:  Douglas Eulálio Antunes; Diogo Fernandes Santos; Mayara Ingrid Sousa Lima; Larissa Pereira Caixeta; Meydson Benjamin Carvalho Correa; Emilly Caroline Dos Santos Moraes; Natalia Carine Almeida Conceição; Luiz Ricardo Goulart; Isabela Maria Bernardes Goulart
Journal:  Front Med (Lausanne)       Date:  2022-07-25

3.  Whole blood RNA signatures in leprosy patients identify reversal reactions before clinical onset: a prospective, multicenter study.

Authors:  Maria Tió-Coma; Anouk van Hooij; Kidist Bobosha; Jolien J van der Ploeg-van Schip; Sayera Banu; Saraswoti Khadge; Pratibha Thapa; Chhatra B Kunwar; Isabela M Goulart; Yonas Bekele; Deanna A Hagge; Milton O Moraes; Rosane M B Teles; Roberta Olmo Pinheiro; Erik W van Zwet; Jelle J Goeman; Abraham Aseffa; Mariëlle C Haks; Tom H M Ottenhoff; Robert L Modlin; Annemieke Geluk
Journal:  Sci Rep       Date:  2019-11-29       Impact factor: 4.379

4.  Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum.

Authors:  Douglas Eulálio Antunes; Isabela Maria Bernardes Goulart; Mayara Ingrid Sousa Lima; Patrícia Terra Alves; Paula Cristina Brígido Tavares; Luiz Ricardo Goulart
Journal:  J Immunol Res       Date:  2019-11-07       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.